Adveritas Ltd
F:4TM
Adveritas Ltd
F:4TM
Price:
0.035
EUR
-2.78%
Market Cap:
€27.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Adveritas Ltd
F:4TM
|
AU |
|
L
|
Lian Beng Group Ltd
F:39Q
|
SG |
|
BioMark Diagnostics Inc
F:20B
|
CA |
|
Almawave SpA
F:101
|
IT |
|
E
|
Eneraqua Technologies PLC
F:Y21
|
UK |
|
U
|
Ucb SA
F:UNC0
|
BE |
|
ValueCommerce Co Ltd
OTC:VCCLF
|
JP |
|
A
|
Arecor Therapeutics PLC
F:6UI
|
UK |
|
Nan Hai Corporation Ltd
F:SO7
|
HK |
|
Guardion Health Sciences Inc
F:0QTA
|
US |
|
CellaVision AB
OTC:CLVSF
|
SE |
Wall St Price Targets
4TM Price Targets Summary
Adveritas Ltd
Adveritas Ltd
Wall Street analysts forecast 4TM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 4TM is 0.177 EUR with a low forecast of 0.176 EUR and a high forecast of 0.183 EUR.
Lowest Forecast
Price Target
0.176
EUR
402% Upside
Average Forecast
Price Target
0.177
EUR
407% Upside
Highest Forecast
Price Target
0.183
EUR
422% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4TM's stock price target?
Price Target
0.177
EUR
0.177
EUR
According to Wall Street analysts, the average 1-year price target for 4TM is 0.177 EUR with a low forecast of 0.176 EUR and a high forecast of 0.183 EUR.
What is the Revenue forecast for Adveritas Ltd?
Projected CAGR
36%
36%
Over the last 11 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 36%.
